Search Within

Sergio Andres Giralt

  1. "Elsevier Inc."
Formats
  1. Meeting Abstract (252)
  2. Journal Article (129)
  3. Guidelines (2)
  4. Research Letter (2)
  5. Review (1)
Groups
  1. Bone Marrow Transplant (386)
  2. Center for Hematologic Malignancies (386)
  3. Department of Medicine (386)
  4. Hematologic Malignancies, Division of (386)
  5. Survivorship Research (270)
  6. CTCR Scholars (221)

More Groups

People
  1. Miguel-Angel Perales (171)
  2. Sean Devlin (145)
  3. Gunjan Shah (122)
  4. Molly Maloy (113)
  5. Ann Jakubowski (112)
  6. Esperanza Papadopoulos (103)

More People

Years
  1. 2025 (3)
  2. 2024 (17)
  3. 2023 (22)
  4. 2022 (26)
  5. 2021 (13)
  6. 2020 (38)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (275)
  2. Clinical Lymphoma, Myeloma and Leukemia (60)
  3. Transplantation and Cellular Therapy (36)
  4. Journal of Geriatric Oncology (3)
  5. International Journal of Radiation Oncology, Biology, Physics (2)
  6. Journal of Pain and Symptom Management (2)

More Publications

Publishers
  1. Elsevier Inc. (386)

Results (386)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reduced intensity conditioning allogeneic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: A single center retrospective analysis in the rituximab era
    Meeting Abstract

    Mussetti, A.; Devlin, S.; Castro-Malaspina, H.; Barker, J. N.; Giralt, S. A.; Sauter, C.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • T-cell depleted allogeneic HSCT for patients with relapsed, high-risk multiple myeloma permits long-lasting remissions in the absence of graft-versus-host disease and provides a platform for adoptive immunotherapeutic approaches
    Meeting Abstract

    Koehne, G.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Safety and efficiency of administering foscarnet in an intensive adult bone marrow transplant clinic: A multidisciplinary approach
    Meeting Abstract

    Kenny, S.; Jackson, L.; Coffey, G.; Eaton, A. A.; Giralt, S.; Barker, J. N.; Harnicar, S.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Prospective PCR monitoring reveals adenovirus (ADV) viremia is associated with a significant risk of ADV disease in T-cell depleted and cord blood allograft recipients
    Meeting Abstract

    Huang, Y. T.; Lee, Y. J.; Kolitsopoulos, Y.; Foldi, J.; Seo, S. K.; Giralt, S. A.; Barker, J. N.; Jakubowski, A. A.; Papanicolaou, G.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Do patients with high risk or relapsed core binding factor acute myeloid leukemia benefit from salvage allogeneic stem cell transplantation?
    Meeting Abstract

    Hobbs, G.; Kishtagari, A.; Hilden, P.; Barker, J. N.; Jakubowski, A. A.; Papadopoulos, E.; Devlin, S.; Boulad, F.; Kernan, N.; Kobos, R.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • A novel reduced intensity conditioning regimen for patients with high risk hematologic malignancies undergoing conventional allogeneic stem cell transplantation
    Meeting Abstract

    Hobbs, G.; Kaur, N.; Ponce, D. M.; Hilden, P.; Castro-Malaspina, H.; Giralt, S. A.; Goldberg, J. D.; Papadopoulos, E.; Jakubowski, A. A.; Sauter, C. S.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Phase I/II study of paclitaxel plus ifosfamide followed by high-dose paclitaxel, ifosfamide, and carboplatin with autologous stem cell reinfusion for salvage treatment of germ cell tumors
    Meeting Abstract

    Feldman, D. R.; Glezerman, I.; Patil, S.; Van Alstine, L.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M.; Reich, L.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Prospective evaluation of alternative donor availability in 708 patients: Improved allograft access with enlarging cord blood (CB) inventory for all patients including racial and ethnic minorities
    Meeting Abstract

    Dahi, P.; Ponce, D. M.; Byam, C.; Devlin, S.; Lubin, M.; Evans, K.; Gonzales, A. M.; Sideroff, M.; Wells, D.; Papadopoulos, E.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Phase 1 trial of carfilzomib + melphalan (CarMel) conditioning and autologous hematopoietic stem cell transplantation (AHSCT) for relapsed multiple myeloma (MM)
    Meeting Abstract

    Costa, L. J.; Landau, H.; Venkata, J. K.; Kang, Y. B.; Koehne, G.; Chung, D. J.; Lendvai, N.; Bentz, T.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Immune reconstitution after autologous stem cell transplantation for multiple myeloma
    Meeting Abstract

    Chung, D. J.; Pronschinske, K. B.; Shyer, J. A.; Wu, V.; Hassoun, H.; Landau, H.; Lendvai, N.; Lesokhin, A. M.; Koehne, G.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save